New Jersey employers cannot run a drug testing program the way they did a decade ago. Recreational cannabis is legal for adults, medical cannabis has its own separate protections, and the state's disability and workers compensation rules layer on top of both. None of this means employers lost the right to a drug free workplace. It means the rules for how and when a positive test can lead to an adverse employment action changed, and employers who have not updated their policy are exposed. This guide walks through what New Jersey law actually requires, where guidance is still developing, and how to build a policy that holds up.
CREAMMA and the end of "cannabis use equals termination"
The Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act, known as CREAMMA, legalized adult use cannabis in New Jersey and rewrote the rules for employer drug testing. The Cannabis Regulatory Commission's workplace and impairment guidance confirms that an employer cannot refuse to hire, discipline, or fire someone solely because that person uses cannabis off duty, and that a positive test result alone is not enough to justify an adverse action. Employers keep the right to maintain a drug free workplace and to prohibit use, possession, or impairment on the job.
The enacted CREAMMA text, on file with the New Jersey Legislature, spells out the mechanics. An employer may require an employee or applicant to take a drug test upon reasonable suspicion of cannabis use while working, after observable signs of intoxication, following a workplace accident, or as part of random or pre employment screening. The law also allows the employer to act on those results, including dismissal, suspension, or demotion, once a proper evaluation has been done. The full employer and drug testing provisions are in the enacted bill text published by the Legislature, which anyone drafting a New Jersey cannabis employment policy should read directly rather than relying on a summary. See the official CREAMMA bill text on the New Jersey Legislature's site, particularly the sections on employer drug testing and licensee and consumer protections.
The Workplace Impairment Recognition Expert concept
CREAMMA directs the Cannabis Regulatory Commission, working with the Police Training Commission, to write regulations creating a Workplace Impairment Recognition Expert certification. A certified WIRE would be trained to help an employer document observable signs of cannabis or other substance impairment, including after a workplace accident, and that documentation would support the physical evaluation the statute calls for alongside a chemical test. The statutory language is in the same CREAMMA bill text cited above.
Employers should not assume WIRE certification standards are finalized or that a certified WIRE is currently required before acting on a positive test. The Cannabis Regulatory Commission's own public workplace guidance describes employers using in house or contracted drug recognition resources to evaluate impairment rather than confirming a completed WIRE certification pipeline. Because this program has moved at its own pace, check the Commission's current workplace guidance before writing a policy that assumes WIRE certification is mandatory or fully operational. Until the Commission's guidance says otherwise, a reasonable suspicion or post accident test paired with a documented, objective evaluation is the defensible approach.
Medical cannabis and the Jake Honig Act
Registered medical cannabis patients have separate and, in some ways, stronger protections under the Jake Honig Compassionate Use Medical Cannabis Act. The enacted amendment on file with the Legislature makes it unlawful to take an adverse employment action against an employee solely because that person is a registered qualifying patient. If an employer has a drug testing policy and an employee or applicant tests positive for cannabis, the employer must give that person written notice of the right to explain the result and an opportunity to present a legitimate medical explanation. The employee or applicant then has three working days to respond, submit an authorization from a health care practitioner or proof of registration, or request a confirmatory retest at their own expense. None of this stops an employer from prohibiting use or possession during work hours or on the premises, and it does not require an employer to violate a federal contract, licensing rule, or federal funding condition. The employment provisions are set out in the Jake Honig Act amendment published by the New Jersey Legislature, in the new section addressing adverse employment action and drug testing policy.
In practice this means a positive test for a registered patient should trigger the notice and explanation process before any discipline decision, not after. A policy that skips straight from "positive result" to "termination" for a registered patient is the fact pattern that draws a claim.
The Law Against Discrimination and disability
New Jersey's Law Against Discrimination protects disability as one of its covered categories and requires employers to provide a reasonable accommodation for a qualifying disability unless it would impose an undue burden, according to the Division on Civil Rights' employment discrimination guidance. Where an employee's underlying medical condition, rather than cannabis use itself, is at issue, employers should route the conversation through the same interactive accommodation process used for any other disability claim, and should not assume that cannabis related accommodation questions are automatically resolved by CREAMMA or the Jake Honig Act alone. Because the interaction between these laws is fact specific, employers facing a real accommodation request should get counsel involved before making a final call.
Workers compensation
New Jersey's workers compensation system is administered by the Department of Labor and Workforce Development's Division of Workers' Compensation, described at the Division's program page. Workers compensation questions that turn on whether intoxication or a positive drug test affects eligibility for benefits after a specific injury are case and evidence specific. Employers should not assume a positive post accident test automatically bars a claim or automatically preserves one; that determination is made through the Division's claims process, and an employer with a live claim in dispute should raise the specific facts with the Division or its own workers compensation carrier rather than rely on a general rule.
Public safety, federal contractors and DOT positions
CREAMMA's employer protections carry a built in carve out. The presence of cannabinoid metabolites, and off duty legal cannabis use generally, cannot be the basis for an adverse action against an employee or applicant unless doing so would put the employer in violation of a federal contract or cause it to lose federal funding. That carve out is why positions regulated under federal drug testing rules, including safety sensitive transportation roles subject to the Department of Transportation's testing program, are treated differently in practice: federal law, not CREAMMA, controls those seats regardless of New Jersey's cannabis laws. Employers with a mixed workforce, some positions federally regulated and some not, need a policy that says so explicitly rather than applying one testing standard company wide.
| Category | Adverse action for off duty cannabis use alone | Testing after suspicion, accident, or randomly | Key source |
|---|---|---|---|
| General adult use employees | Not permitted solely on that basis | Permitted with proper evaluation | CREAMMA, CRC workplace guidance |
| Registered medical cannabis patients | Not permitted solely on registrant status | Permitted, but notice and explanation process required before discipline | Jake Honig Act, Section 9 |
| Employees with a qualifying disability | Reasonable accommodation analysis applies | Case specific, route through interactive process | NJ Law Against Discrimination |
| Federal contractor or federally funded positions | Federal contract carve out may apply | Employer may need to follow federal standard | CREAMMA Section 47 to 48 carve out |
| DOT regulated safety sensitive roles | Governed by federal rule, not state cannabis law | Federal testing program controls | Employer's DOT program, outside CREAMMA |
Building a compliant New Jersey policy
- Separate your policy into general workforce rules and any federally regulated positions, and say plainly which employees fall into each category.
- Define reasonable suspicion, post accident, and random testing triggers in writing, and train supervisors on what an observable sign of impairment looks like before they ever call for a test.
- Build the Jake Honig Act notice and explanation step into your process for every positive cannabis result, not just ones you suspect involve a registered patient. Give written notice of the right to explain and hold the three working day window before finalizing any decision.
- Do not represent any internal reviewer as a certified Workplace Impairment Recognition Expert unless that person actually holds a certification recognized under the Commission's finalized standards. Check current Commission guidance before using the WIRE label in policy documents.
- Keep a documented, objective record for every reasonable suspicion or post accident test: what was observed, who observed it, and what testing method was used.
- Route disability related accommodation questions to HR and counsel through the standard interactive process rather than treating them as a cannabis policy question alone.
- If any part of your workforce is federally regulated, keep that testing program entirely separate from your general CREAMMA compliant policy so the two do not get applied to the wrong group of employees.
For background on how testing policies vary once you look beyond New Jersey, see Workplace Drug Testing Laws by State: What Employers Need to Map and Marijuana Legalization and Workplace Drug Testing: What Employers Can Still Do. Employers building or updating a testing program can review options at our drug test cup collection.
Frequently asked questions
Can a New Jersey employer refuse to hire someone because they use cannabis?
Not solely for that reason. CREAMMA prohibits refusing to hire, disciplining, or firing an employee or applicant based only on off duty cannabis use or the presence of cannabinoid metabolites in a test. An employer can still require a drug test, evaluate the result, and act if the evaluation supports impairment on the job or a policy violation such as possession or use at work.
Is Workplace Impairment Recognition Expert certification required before an employer can act on a positive test?
CREAMMA directs the Cannabis Regulatory Commission to establish standards for a WIRE certification, but employers should confirm the current status of that program on the Commission's own workplace guidance before assuming a certified WIRE is mandatory. A documented, objective evaluation paired with a reasonable suspicion, random, or post accident test is the framework the law describes.
Do registered medical cannabis patients get extra protection from a positive drug test?
Yes. Under the Jake Honig Act, if a registered qualifying patient tests positive, the employer must provide written notice of the right to explain and give the employee or applicant three working days to respond with a medical explanation, an authorization from a health care practitioner, proof of registration, or a request for a confirmatory retest at their own expense, before finalizing an adverse action.
Does New Jersey law require employers to accommodate cannabis use or impairment on the job?
No. CREAMMA and the Jake Honig Act do not require an employer to permit use, possession, or impairment during work hours or on the premises, and employers keep the right to maintain a drug free workplace policy for on duty conduct.
Are DOT regulated positions covered by New Jersey's cannabis employment protections?
CREAMMA includes a carve out for situations where extending its protections would put an employer in violation of a federal contract or cause a loss of federal funding. Positions subject to federal safety sensitive testing rules are generally governed by that federal program rather than New Jersey's cannabis law, so employers with a mixed workforce need separate, clearly labeled policies for each group.
What should a New Jersey workers compensation claim involving a positive drug test include?
How intoxication or a positive test affects a specific workers compensation claim depends on the facts of that claim and is handled through the Division of Workers' Compensation's process. Employers should not assume a blanket rule either way and should direct claim specific questions to the Division or their workers compensation carrier.
This article is general information about New Jersey law as of the sources cited and is not legal advice. Employers should consult qualified employment counsel before adopting or changing a drug testing policy.
